HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Innis, R. B. Articles by Hoffer, P. B. Search for Related Content PubMed PubMed Citation Articles by Innis, R. B. Articles by Hoffer, P. B.

SPECT Imaging of the Benzodiazepine Receptor: Feasibility of In Vivo Potency Measurements From Stepwise Displacement Curves

Departments of Psychiatry and Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut
West Haven VA Medical Center, West Haven, Connecticut

Correspondence: For reprints contact: Robert B. Innis, MD, PhD, Psychiatry Service/116A2. VA Medical Center, West Haven, CT 06516.

ABSTRACT

Iodine-123-labeled Ro 16-0154 is a high affinity, reversibly binding radiotracer for the benzodiazepine (BZ) receptor. Brain uptake of this radioligand was relatively stable and showed high ratios of specific-to-nonspecific uptake, with greater than 90% displaced by intravenous administration of BZ receptor agents. Repeated injections of increasing doses of each of five BZ drugs (Ro 16-0154, Ro 15-1788, clonazepam, alprazolam, and diazepam) yielded stepwise displacement curves, which were analyzed to measure the in vivo potencies of these agents. The relatively long half-life of ¹²³I and the stable biologic uptake of the radiotracer allowed such potency estimations in just one experiment following a single injection of radioligand. The in vivo potencies of these five agents were highly correlated with their affinities for the BZ receptor determined with in vitro homogenate binding. A single crystal probe provided potency measurements virtually identical to simultaneously performed SPECT imaging studies. In conclusion, stepwise displacement by agents administered following the injection of the radioligand ¹²³I-Ro 16-0154 provided a reliable means of measuring the in vivo potencies of BZ receptor agents. This in vivo determination may predict the clinical potency of BZ drugs than in vitro homogenate estimations, because the in vivo measure provides the summed effects of receptor affinity, plasma protein binding, penetration of the blood-brain barrier, and metabolism of the displacing agent.

This article has been cited by other articles:

				D. Saur, R. Buchert, R. Knab, C. Weiller, and J. Rother Iomazenil-Single-Photon Emission Computed Tomography Reveals Selective Neuronal Loss in Magnetic Resonance-Defined Mismatch Areas Stroke, November 1, 2006; 37(11): 2713 - 2719. [Abstract] [Full Text] [PDF]

				J. K. Staley, C. Gottschalk, I. L. Petrakis, R. Gueorguieva, S. O'Malley, R. Baldwin, P. Jatlow, N. P. L. G. Verhoeff, E. Perry, D. Weinzimmer, et al. Cortical {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptors in Recovery From Alcohol Dependence: Relationship to Features of Alcohol Dependence and Cigarette Smoking Arch Gen Psychiatry, August 1, 2005; 62(8): 877 - 888. [Abstract] [Full Text] [PDF]

				W.-D. Heiss, R. Graf, T. Fujita, K. Ohta, B. Bauer, J. Lottgen, and K. Wienhard Early Detection of Irreversibly Damaged Ischemic Tissue by Flumazenil Positron Emission Tomography in Cats Stroke, October 1, 1997; 28(10): 2045 - 2052. [Abstract] [Full Text]

				Y. Dong, H. Fukuyama, H. Nabatame, H. Yamauchi, H. Shibasaki, and Y. Yonekura Assessment of Benzodiazepine Receptors Using Iodine-123–Labeled Iomazenil Single-Photon Emission Computed Tomography in Patients With Ischemic Cerebrovascular Disease : A Comparison With PET Study Stroke, September 1, 1997; 28(9): 1776 - 1782. [Abstract] [Full Text]

				C. I. Okocha, F. Kapczinski, N. Lassen, and M. H. Lader Central benzodiazepine receptor imaging and quantitation with single photon emission computerised tomography: SPECT J Psychopharmacol, January 1, 1995; 9(4): 369 - 380. [Abstract] [PDF]